In a report released today, Daniel Arias from Stifel Nicolaus maintained a Buy rating on Codexis (CDXS – Research Report), with a price target of $5.00. The company’s shares closed
In a report released today, Daniel Arias from Stifel Nicolaus maintained a Buy rating on Codexis (CDXS – Research Report), with a price target of $5.00. The company’s shares closed
TD Cowen analyst Brendan Smith maintained a Hold rating on Codexis (CDXS – Research Report) today and set a price target of $3.00. The company’s shares closed yesterday at $3.74.
An update from Codexis ( ($CDXS) ) is now available. Codexis, Inc. has appointed Raymond De Vré as a new Class I director to its Board, enhancing its leadership with
In a report released today, Matt Hewitt from Craig-Hallum maintained a Buy rating on Codexis (CDXS – Research Report). The company’s shares closed yesterday at $4.06. Hewitt covers the Healthcare
Benchmark Co. analyst Robert Wasserman maintained a Hold rating on Codexis (CDXS – Research Report) today. The company’s shares closed last Friday at $3.50. Wasserman covers the Healthcare sector, focusing